ALL vs ANIK · P/E 4.9, rev $18.60B vs rev $62.2M
The Allstate Corporation (ALL) versus Anika Therapeutics Inc (ANIK) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Anika Therapeutics Inc (ANIK) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ALL revenue for 2026-06-30 was $18.60B. Net income was $3.27B. Revenue was up 9.8% from 2026-03-31 to 2026-06-30. ALL currently screens at market cap $56.89B and trailing P/E 4.9.
Latest reported ANIK revenue for 2026-06-30 was $62.2M. Net income was -$1.7M. ANIK currently screens at market cap $161.3M.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. ANIK currently screens at market cap $161.3M.
Not investment advice. Open the ALL and ANIK stock pages for the full models.
Not investment advice.